4-Antibody AG
4-Antibody AG develops human antibody drug-discovery platform for generating antibody therapeutics focused on immuno-oncology.
4-Antibody AG is a business in biotechnology, health care, medical, oncology, therapeutics based in Europe, Middle East, and Africa (EMEA), founded in 2002.
Within the biotechnology, health care, medical, oncology, therapeutics space, the company focuses on its core offering rather than a broad product line.
The business is associated with Europe, Middle East, and Africa (EMEA).
It is recorded at the Series_A stage.
Its team size is recorded as c_00251_00500 employees.
Public records show total funding of about $25.8M.
| Sector | Biotechnology, Health Care, Medical, Oncology, Therapeutics |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2002 |
| Employees | c_00251_00500 |
| Stage | series_a |
| Total funding | $25,750,000 |
Website: www.4-antibody.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account